NeuroMetrix, Inc. (NURO)
USD 4.47
(1.08%)
USD 4.47
(1.08%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 92.48 Thousand USD | -55.43% |
| 2022 | 207.51 Thousand USD | -32.34% |
| 2021 | 306.7 Thousand USD | -33.53% |
| 2020 | 461.41 Thousand USD | -49.66% |
| 2019 | 916.67 Thousand USD | -29.55% |
| 2018 | 1.3 Million USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | -100.0% |
| 2011 | 17.92 Thousand USD | -53.13% |
| 2010 | 38.24 Thousand USD | 15.12% |
| 2009 | 33.22 Thousand USD | -36.18% |
| 2008 | 52.05 Thousand USD | 184.86% |
| 2007 | 18.27 Thousand USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | -100.0% |
| 2003 | 2.04 Million USD | 0.0% |
| 2002 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 28.21 Thousand USD | 0.0% |
| 2024 Q3 | - USD | 0.0% |
| 2024 Q1 | 60.94 Thousand USD | 0.0% |
| 2023 Q1 | 180.34 Thousand USD | -13.09% |
| 2023 FY | 92.48 Thousand USD | -55.43% |
| 2023 Q4 | 92.48 Thousand USD | -24.73% |
| 2023 Q3 | 122.87 Thousand USD | -19.24% |
| 2023 Q2 | 152.14 Thousand USD | -15.64% |
| 2022 FY | 207.51 Thousand USD | -32.34% |
| 2022 Q1 | 283.2 Thousand USD | -7.66% |
| 2022 Q2 | 258.91 Thousand USD | -8.58% |
| 2022 Q3 | 233.69 Thousand USD | -9.74% |
| 2022 Q4 | 207.51 Thousand USD | -11.2% |
| 2021 FY | 306.7 Thousand USD | -33.53% |
| 2021 Q4 | 306.7 Thousand USD | -6.82% |
| 2021 Q1 | 371.82 Thousand USD | -19.42% |
| 2021 Q2 | 350.89 Thousand USD | -5.63% |
| 2021 Q3 | 329.16 Thousand USD | -6.19% |
| 2020 Q2 | 698.12 Thousand USD | -13.84% |
| 2020 Q1 | 810.23 Thousand USD | -11.61% |
| 2020 Q3 | 581.9 Thousand USD | -16.65% |
| 2020 Q4 | 461.41 Thousand USD | -20.71% |
| 2020 FY | 461.41 Thousand USD | -49.66% |
| 2019 Q4 | 916.67 Thousand USD | -10.0% |
| 2019 Q2 | 1.11 Million USD | -7.82% |
| 2019 Q1 | 1.21 Million USD | -6.89% |
| 2019 FY | 916.67 Thousand USD | -29.55% |
| 2019 Q3 | 1.01 Million USD | -8.8% |
| 2018 FY | 1.3 Million USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q4 | 1.3 Million USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2012 Q2 | 7283.00 USD | -42.42% |
| 2012 Q3 | 1835.00 USD | -74.8% |
| 2012 Q4 | - USD | -100.0% |
| 2012 Q1 | 12.64 Thousand USD | -29.46% |
| 2012 FY | - USD | -100.0% |
| 2011 FY | 17.92 Thousand USD | -53.13% |
| 2011 Q1 | 31.61 Thousand USD | -17.34% |
| 2011 Q4 | 17.92 Thousand USD | -22.48% |
| 2011 Q3 | 23.12 Thousand USD | -13.83% |
| 2011 Q2 | 26.84 Thousand USD | -15.11% |
| 2010 FY | 38.24 Thousand USD | 15.12% |
| 2010 Q3 | 3707.00 USD | -74.06% |
| 2010 Q4 | 38.24 Thousand USD | 931.8% |
| 2010 Q2 | 14.28 Thousand USD | -40.73% |
| 2010 Q1 | 24.11 Thousand USD | -27.43% |
| 2009 Q1 | 56.82 Thousand USD | 9.15% |
| 2009 FY | 33.22 Thousand USD | -36.18% |
| 2009 Q4 | 33.22 Thousand USD | -20.29% |
| 2009 Q3 | 41.68 Thousand USD | -15.85% |
| 2009 Q2 | 49.53 Thousand USD | -12.82% |
| 2008 Q2 | 11.82 Thousand USD | -21.43% |
| 2008 Q1 | 15.05 Thousand USD | -17.65% |
| 2008 Q4 | 52.05 Thousand USD | 505.34% |
| 2008 Q3 | 8600.00 USD | -27.27% |
| 2008 FY | 52.05 Thousand USD | 184.86% |
| 2007 Q3 | 21.5 Thousand USD | -16.67% |
| 2007 Q1 | - USD | 0.0% |
| 2007 FY | 18.27 Thousand USD | 0.0% |
| 2007 Q4 | 18.27 Thousand USD | -15.0% |
| 2007 Q2 | 25.8 Thousand USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2004 Q2 | 1.6 Million USD | -7.48% |
| 2004 Q3 | - USD | -100.0% |
| 2004 FY | - USD | -100.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q1 | 1.73 Million USD | -15.4% |
| 2003 FY | 2.04 Million USD | 0.0% |
| 2003 Q4 | 2.04 Million USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 36.1 Million USD | 99.744% |
| BrainsWay Ltd. | 239 Thousand USD | 61.303% |
| Cerus Corporation | 59.79 Million USD | 99.845% |
| Envoy Medical, Inc. | 404 Thousand USD | 77.108% |
| electroCore, Inc. | 537 Thousand USD | 82.777% |
| Helius Medical Technologies, Inc. | 12 Thousand USD | -670.708% |
| IceCure Medical Ltd | 376 Thousand USD | 75.403% |
| Inogen, Inc. | 18.27 Million USD | 99.494% |
| OrthoPediatrics Corp. | 13.45 Million USD | 99.313% |
| Lucid Diagnostics Inc. | 199 Thousand USD | 53.525% |
| Monogram Orthopaedics, Inc. | 363.72 Thousand USD | 74.573% |
| MaxCyte, Inc. | 17.96 Million USD | 99.485% |
| NeuroOne Medical Technologies Corporation | 55.28 Thousand USD | -67.291% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| Orthofix Medical Inc. | 93.1 Million USD | 99.901% |
| PAVmed Inc | 2.96 Million USD | 96.876% |
| Rapid Micro Biosystems, Inc. | 6.21 Million USD | 98.512% |
| RxSight, Inc. | 1.21 Million USD | 92.363% |
| Sight Sciences, Inc. | 31.7 Million USD | 99.708% |
| SI-BONE, Inc. | 36.06 Million USD | 99.744% |
| TELA Bio, Inc. | 40.51 Million USD | 99.772% |
| Treace Medical Concepts, Inc. | 53 Million USD | 99.826% |
| Vivos Therapeutics, Inc. | 1.52 Million USD | 93.919% |
| Acutus Medical, Inc. | 32.65 Million USD | 99.717% |
| Talis Biomedical Corporation | 16.78 Million USD | 99.449% |
| Spectral AI, Inc. | - USD | -Infinity% |
| Nano-X Imaging Ltd. | 4.04 Million USD | 97.714% |
| CVRx, Inc. | 30.38 Million USD | 99.696% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 1.01 Million USD | 90.905% |
| Bioventus Inc. | 366.99 Million USD | 99.975% |
| Venus Concept Inc. | 70.79 Million USD | 99.869% |
| TriSalus Life Sciences, Inc. | 1.24 Million USD | 92.566% |
| LivaNova PLC | 568.54 Million USD | 99.984% |
| 908 Devices Inc. | 3.92 Million USD | 97.646% |
| Alphatec Holdings, Inc. | 511.03 Million USD | 99.982% |
| Nemaura Medical Inc. | 3.08 Million USD | 97.005% |
| NeuroPace, Inc. | 56.95 Million USD | 99.838% |
| LENSAR, Inc. | 1.75 Million USD | 94.715% |
| Apyx Medical Corporation | 33.18 Million USD | 99.721% |
| Cutera, Inc. | 418.69 Million USD | 99.978% |
| STRATA Skin Sciences, Inc. | 15.04 Million USD | 99.385% |
| BioSig Technologies, Inc. | 103 Thousand USD | 10.209% |
| Anika Therapeutics, Inc. | 26.9 Million USD | 99.656% |
| ClearPoint Neuro, Inc. | 9.94 Million USD | 99.07% |
| Integra LifeSciences Holdings Corporation | 1.48 Billion USD | 99.994% |
| Axonics, Inc. | 25.84 Million USD | 99.642% |
| Outset Medical, Inc. | 134.59 Million USD | 99.931% |
| IRIDEX Corporation | 1.75 Million USD | 94.718% |
| PROCEPT BioRobotics Corporation | 51.33 Million USD | 99.82% |
| IRadimed Corporation | 1.61 Million USD | 94.274% |
| Tivic Health Systems, Inc. | 176 Thousand USD | 47.452% |
| INVO Bioscience, Inc. | 6.77 Million USD | 98.635% |
| Telesis Bio, Inc. | 5.26 Million USD | 98.245% |
| Viemed Healthcare, Inc. | 5.97 Million USD | 98.451% |
| Varex Imaging Corporation | 464.2 Million USD | 99.98% |
| Quipt Home Medical Corp. | 60.82 Million USD | 99.848% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | 84.271% |
| Pulmonx Corporation | 35.08 Million USD | 99.736% |
| Dynatronics Corporation | 3.25 Million USD | 97.162% |
| Modular Medical, Inc. | 817 Thousand USD | 88.68% |
| ReShape Lifesciences Inc. | 151 Thousand USD | 38.752% |
| Semler Scientific, Inc. | 70 Thousand USD | -32.121% |
| InMode Ltd. | 6.61 Million USD | 98.601% |
| Bruker Corporation | 1.14 Billion USD | 99.992% |
| Cytosorbents Corporation | 2.54 Million USD | 96.363% |
| DexCom, Inc. | 2.57 Billion USD | 99.996% |
| Align Technology, Inc. | 96.96 Million USD | 99.905% |
| Viveve Medical, Inc. | 5.12 Million USD | 98.195% |
| ZimVie Inc. | 508.79 Million USD | 99.982% |
| Movano Inc. | 15.00 USD | -616466.667% |
| Cytek Biosciences, Inc. | 18.12 Million USD | 99.49% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 398.6 Million USD | 99.977% |
| Profound Medical Corp. | 4.97 Million USD | 98.141% |
| Insulet Corporation | 1.36 Billion USD | 99.993% |
| enVVeno Medical Corporation | 1.06 Million USD | 91.308% |
| Surmodics, Inc. | 29.4 Million USD | 99.685% |
| iCAD, Inc. | 273 Thousand USD | 66.123% |
| Nuwellis, Inc. | 221 Thousand USD | 58.152% |
| Biotricity, Inc. | 10.85 Million USD | 99.148% |
| iRhythm Technologies, Inc. | 34.95 Million USD | 99.735% |
| Aethlon Medical, Inc. | 649.75 Thousand USD | 85.766% |
| InspireMD, Inc. | 1.03 Million USD | 91.09% |
| PAVmed Inc. | 2.96 Million USD | 96.876% |
| BIOLASE, Inc. | 13.98 Million USD | 99.339% |
| Beyond Air, Inc. | 14.72 Million USD | 99.372% |
| FONAR Corporation | 37.92 Million USD | 99.756% |
| AxoGen, Inc. | 46.6 Million USD | 99.802% |
| Vivani Medical, Inc. | 19.31 Million USD | 99.521% |
| Tactile Systems Technology, Inc. | 44.61 Million USD | 99.793% |
| Inari Medical, Inc. | 30.35 Million USD | 99.695% |
| UFP Technologies, Inc. | 28 Million USD | 99.67% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 434.04 Thousand USD | 78.692% |
| Tenon Medical, Inc. | 428 Thousand USD | 78.391% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | 90.77% |
| Co-Diagnostics, Inc. | 2.15 Million USD | 95.703% |
| AdaptHealth Corp. | 2.09 Billion USD | 99.996% |
| Sintx Technologies, Inc. | 3.68 Million USD | 97.492% |
| NanoVibronix, Inc. | - USD | -Infinity% |
| Quanterix Corporation | 37.22 Million USD | 99.752% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | 84.271% |
| Sensus Healthcare, Inc. | 596 Thousand USD | 84.482% |
| Pacific Biosciences of California, Inc. | 892.24 Million USD | 99.99% |
| TransMedics Group, Inc. | 506.2 Million USD | 99.982% |
| ReWalk Robotics Ltd. | 607 Thousand USD | 84.764% |
| Hyperfine, Inc. | 64 Thousand USD | -44.508% |
| Establishment Labs Holdings Inc. | 188.73 Million USD | 99.951% |
| Biomerica, Inc. | 459 Thousand USD | 79.851% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | 79.424% |
| Bluejay Diagnostics, Inc. | 189.98 Thousand USD | 51.32% |
| Silk Road Medical, Inc | 75.62 Million USD | 99.878% |